Sumaham, Glenn R.

HRN: 27-58-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
OXACILLIN 500MG (VIAL)
08/13/2025
08/19/2025
IVTT
500 Mg
Q6
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Culture-directed    Type of Infection:  Bloodstream    Compliance to guidelines: